• No results found

University of Groningen Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery Konstantinidou, Markella

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery Konstantinidou, Markella"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Multicomponent reactions, applications in medicinal chemistry & new modalities in drug

discovery

Konstantinidou, Markella

DOI:

10.33612/diss.111908148

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Konstantinidou, M. (2020). Multicomponent reactions, applications in medicinal chemistry & new modalities in drug discovery. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.111908148

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

APPENDIX

ABOUT THE AUTHOR

PUBLICATIONS

CONFERENCES

ACKNOWLEDGEMENTS

(3)

322

ABOUT THE AUTHOR

Markella was born on the 21st of April 1989 in Thessaloniki, Greece. In July 2012 she graduated with

a Degree in Pharmacy from the Aristotle University of Thessaloniki, Greece. In the same University she pursued post-graduate studies and in 2014 she obtained her MSc in Medicinal Chemistry. Her MSc thesis entitled “Design and synthesis of biologically active compounds bearing the cinnamic / propenonic scaffold” was performed under the supervision of Prof. Dimitra Hadjipavlou – Litina. Shortly after completing her master studies, she was employed as a research assistant at the Institute of Biology, Medicinal Chemistry and Biotechnology in the National Hellenic Research Foundation in Athens. She performed multi-step synthesis of dendrimers with biological applications under the supervision of Dr. Barry Steele and Dr. George Heropoulos. In February 2016, she moved to Groningen to pursue doctoral studies under the supervision of Prof. Alexander Dömling, in the group of Drug Design at the Department of Pharmacy. Her research focused on novel synthetic methodologies based on multicomponent reactions, applications in medicinal chemistry and new modalities, such as proteolysis targeting chimeras in drug discovery. During her PhD, she did a 3-month secondment in AstraZeneca, in Gotherburg, Sweden, focusing on virtual screening and docking, under the supervision of Dr. Hongming Chen. Her PhD position was part of a Marie Curie ITN network with the acronym AEGIS (accelerated early stage drug discovery).

(4)

PUBLICATIONS

1 M. Konstantinidou, J. Li, B. Zhang, Z. Wang, S. Shaabani, F. ter Brake, K. Essa, A.Dömling, PROTACs

– a game changing technology, Expert Opinion on Drug Discovery 2019, 14, 1255 – 1268, DOI:

10.1080/17460441.2019.1659242

2. Q. Wang, K.C. Mgimpatsang, M. Konstantinidou, S. V. Shishkina, A. Dömling, 1,3,4-Oxadiazoles

by Ugi-tetrazole and Huisgen reactions, Organic Letters 2019,21, 7320 – 7323, DOI: 10.1021/acs.

orglett.9b02614

3. Q. Wang, A. Osipyan, M. Konstantinidou, R. Butera, K. C. Mgimpatsang, S. V. Shishkina, A. Dömling, Pd-Catalyzed de novo assembly of diversely substituted indole-fused polyheterocycles,

Journal of Organic Chemistry 2019, 84, 12148 – 12156, DOI: 10.1021/acs.joc.9b01258

4. S. Kurhade,†M. Konstantinidou,†F.Sutanto, K. Kurpiewska, J. Kalinowska –Tłuścik, A. Dömling,

SEQUENTIAL MULTICOMPONENT SYNTHESIS OF 2-(IMIDAZO[1,5-α]PYRIDIN-1-YL)-1,3,4-OXADIAZOLES, European Journal of Organic Chemistry 2019, 10, 2029-2034, DOI: 10.1002/ejoc.201801880

5. R.Madhavachary,† N.Naveen,† Y. Wang, Q. Wang, M. Konstantinidou, A. Dömling,

beta-Carbolinone analogues from the Ugi silver mine, European Journal of Organic Chemistry 2018, 24,

3139-3143, DOI: 10.1002/ejoc.201800557

6. M. Konstantinidou, K. Kurpiewska, J. Kalinowska-Tłuscik, A. Dömling, Glutarimide alkaloids

through multicomponent reaction chemistry, European Journal of Organic Chemistry 2018, 47,

6714-6719, DOI: 10.1002/ejoc.201801276

7. M.Konstantinidou, T. Zarganes – Tzitzikas, K. Magiera, T.A. Holak, A. Dömling, Immune Checkpoint

PD-1/PD-L1: Is there life beyond antibodies? Angewandte Chemie International Edition 2018, 57,

4840-4848, DOI: 10.1002/anie.201710407

8. T. Zarganes-Tzitzikas, M. Konstantinidou, Y. Gao, D. Krzemien, K. Zak, G. Dubin, T.A. Holak, A. Dömling. Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015), Expert Opinion on

Therapeutic Patents 2016, 26, 973-977, DOI:10.1080/13543776.2016.1206527

9. M. Konstantinidou, A. Gkermani, D. Hadjipavlou-Litina, Synthesis and pharmacochemistry of new

pleiotropic pyrrolyl derivatives, Molecules 2015, 20, 16354-16374, DOI:10.3390/molecules200916354

10. A. Vronteli, D. Hadjipavlou-Litina, M. Konstantinidou, K.E. Litinas, Synthesis of fused

Pyranocarbazolones with biological interest, Arkivoc 2015 (iii) 111-123, DOI: 10.3998/ark.5550190.

p009.004

11. M. Konstantinidou, D. Hadjipavlou-Litina, Cytokines in terms of QSAR. Review, evaluation,

(5)

324

CONFERENCES

Oral presentations

1. Discovery of proteolysis targeting chimeras for leucine-rich repeat kinase 2 (LRRK2), New Frontiers in structure-based drug discovery, 23-25/9/2019, Florence, Italy

2. Tetrazole and oxadiazole heterocycles via multicomponent reaction schemes, ACS Fall National Meeting, 25-29/8/2019, San Diego, USA

3. Design of a multicomponent reaction scaffold with inhibitory activity on aspartic proteases, ACS Fall National Meeting, 25-29/8/2019, San Diego, USA

4. Applications of multicomponent reaction chemistry in heterocyclic synthesis, ACS Spring National Meeting, 31/3-1/4/2019, Orlando, USA

5. Design of a MCR scaffold with inhibitory activity on aspartic proteases, 7th International

Conference on Multicomponent Reactions and Related Chemistry, 26-31/8/2018, Düsseldorf, Germany

6. Discovery of unprecedented aspartic-protease inhibitors with applications in Alzheimer and

other diseases, 25th Young Research Meeting, SCT, 5-7/3/2018, Orleans, France

Poster presentations

1. Recent advances in heterocyclic synthesis via multicomponent reaction schemes, EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC), 1-5/9/2019, Athens, Greece

2. Inhibitors for Asp-proteases: anchor-based virtual screening, innovative chemistry and

protein crystallography, ACS Spring National Meeting, 31/3-1/4/2019, Orlando, USA

3. Discovery of unprecedented aspartic-protease inhibitors with applications in Alzheimer and

other diseases,FIGON Dutch Medicine Days 1-2/10/2018

4. Design and synthesis of small molecules as protein-protein interaction stabilizers,5th EFMC

Young Medicinal Chemist Symposium (EFMC-YMCS) 6-7/9/2018, Ljubljana, Slovenia

5. From fragment hits to MCR small molecules: design, synthesis and biological evaluation,, XXV EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC) 2-6/9/2018, Ljubljana, Slovenia

6. Glutarimide alkaloids via MCR chemistry, 53rd International Conference on Medicinal Chemistry,

5-7/7/2017, Toulouse, France

7. New glycodendrimers as potential carriers for anticancer drugs, Frontiers in Medicinal Chemistry, 14-16/9/2015, Antwerp, Belgium

8. Synthesis of new poly-hydroxy-dendrimers as iron chelators, 12th Chemistry Conference

Greece-Cyprus, 8-10/5/2015, Thessaloniki, Greece

9. Design and synthesis of acrylic acid derivatives, 21st Young Research Fellow Meeting,

24-25/03/2014, Montpellier, France

10. Synthesis and biological evaluation of structurally modified acrylic acid derivatives, 16th

Hellenic Pharmaceutical Congress, 31/05-03/06/2013, Athens, Greece

11. QSAR of CXCR2 chemokine receptor antagonists as potent anti-inflammatory agents, 19thEuroQSAR, 26-30/08/2012, Vienna, Austria

12. QSAR of interleukin inhibitors and antagonists: a tool for anti-inflammatory drug design, 15th Hellenic Symposium on Medicinal Chemistry, 25-27/05/2012, Athens, Greece

(6)

ACKNOWLEDGEMENTS

This is the end of the four years of my PhD journey in the Netherlands. In retrospect, it was an amazing experience not only scientifically, but also personally. Here I would like to express my gratitude to the people who shared this journey with me and made it truly memorable.

First and foremost, I am truly grateful to my supervisor Prof. Alex Dömling for giving me the opportunity to join the Drug Design group as a PhD fellow within the ITN AEGIS. Your support, guidance and persistent enthusiasm about new ideas and projects are really remarkable. You greeted me every morning with a “kalimera” and invited me to lovely dinners with excellent wine. I was involved in numerous projects in the lab and you always gave me freedom and listened to my ideas, allowing me to work independently. I would really like to thank you for giving me the chance to attend and present my work in international conferences and in particular the two ACS meetings in my last year. Many thanks for giving me the chance to learn your unique chemistry of multicomponent reactions (MCRs) and for getting me involved in the new modality of PROTACs. Thank you for everything!!!

I would also like to thank my co-promotor Prof. Tad Holak for the smooth and fruitful collaborations. It was a pleasure to meet you in the conference in Toulouse.

Moreover, I would like to acknowledge Dr. Hongming Chen and Dr. Ola Engkvist for the enjoyable stay in AstraZeneca, Gothenburg. During those three months I learned a lot regarding computational chemistry and had the chance to experience the industrial aspect of drug discovery. I would also like to thank the members of the reading committee: Prof. Frank Dekker, Prof. Philip Elsinga and Prof. Romano Orru for their time and effort to evaluate and approve the thesis. Next, I would like to acknowledge Dr. Matthew Groves for introducing me to structural biology during my short stay in his lab.

Many thanks to Prof. Carlos Camacho for helping me with the AnchorQuery software, the interesting conversations and for being good company in the AEGIS schools.

My AEGIS fellows and friends, Ave, Joy, Ryan, Roberto, Maxime, Atilio, Charlie, Engi, Francesca, Valeria, Patrick, João, Giulia, Laura, you made this experience truly unique since the first time we met in Munich. I have great memories from the winter and summer schools in Uppsala, Munich, Groningen, Basel, Paris and Florence. I wish you all the best in your future steps. I am also grateful to Dr. Eva Schlosser for the coordination, help and support within the AEGIS consortium. Many

(7)

326

Jolanda, you always greeted me with a smile and you were extremely helpful with various administrative issues, conferences and sending packages. Thanks a lot!

I am grateful to our lab manager Dr. André Boltjes for his invaluable contribution in maintaining the lab in a non-chaotic state. You were always eager to discuss chemistry problems and gave me valuable advice. I enjoyed working with you on the adenine mimetics project. Thank you very much for helping me with the procedures for the thesis. I wish you all the best!

Robin, our second lab manager, thank you for translating the summary of my thesis in Dutch. You were always eager to assist in equipment problems. You have a great sense of humour and of course the superpower of scheduling me for presentations in the lab meetings on the days that I was not there. Probably at a certain point I will start missing your unconventional music choices in the lab. I would like to express my gratitude to my dear friends and paranymphs Qian and Jingyao. Qian, you are truly a “cosmopolitan” Chinese. You were always greeting me with a big smile. I really enjoyed collaborating with you. You are very hard-working and your contribution in various projects was truly valuable. I will miss you enthusiasm and your singing in the lab. Jingyao, my former office mate, it was always a pleasure discussing with you. Both of you were the first Chinese I met in the lab and introduced me to Chinese food, music and cultural aspects that I was unaware of. I hope we can meet once in your beautiful county.

Roberto, one of my current office mates, I really enjoyed all the conversations regarding troubleshooting chemistry problems and discussing interesting old-school chemistry reactions (which seem to be your favourite) and the more recent palladium-catalyzed reactions that we performed together successfully. You somehow combine the Sicilian spirit (and cooking skills) with the German discipline and hard work.

Fandi, Ruixue, Zefeng, Bidong, Li it was a pleasure working with you all. Thank you for the interesting Indonesian and Chinese dinners. It made me really happy attending the conference in Athens with you and introducing you to Greek food (and Greek islands).

I would also like to thank all the current lab members Xin, Qiang, Maryam, Angelina, Marta W, Angel, Mosjan, Patil, Shabnam for the nice atmosphere in the lab and also the members of the structural biology lab Kai, Fernando, Wenja, Sergey, Juliana for welcoming me there and teaching me the secrets of the “dark side”.

I am grateful to former members of the lab Natalia, Edwin, Eman, Vishnu, Yuanze, Naveen, Ajay. It was a pleasure meeting you all. Santosh, my friend, a learned a lot from you. We had plenty of interesting discussions and collaborated very well together. I really enjoyed the stories you shared during lunch time about India.

(8)

Over the years we had so many visiting students from all over the world. I would like to thank in particular Arianna, with whom I have great memories from my first year in the lab, including Dutch courses, dinners and numerous trips within the Netherlands. It was a pleasant surprise to see you again recently in the conference in Athens.

I would also like to thank my former students Zlata and Dario. You were both hard-working, diligent and I really enjoyed working with you. Hope to see you again.

Many thanks to visiting students that made the lab truly international: Marta F, Federica, Francesca, Sara, Antonio, Miska, Tatiana, Max, Kees, Harmen, Elmar, Michel, Perry, Gita, Vincenzo, Kumchok, Martin, Danielle, Paola, Renan, Frans, Khaled, Robert, Salomão, Oliver (thanks for the great drawings on the fumehoods) and many many more.

This whole experience would have been completely different and probably less fun without our small Greek community. Dinos, Tryfonas, Nikos, Giorgos, Evi, Valanto, Georgia, Despoina, Tassis thank you having me in your company and enjoying together Saturday coffees, drinks, dinners, PhD defences and much more. Dinos and Tryfonas, the original Greeks of the Drug Design Group, I cannot thank you enough for your help, solidarity and friendship not only in the lab, but also in our everyday life. Your chemistry expertise and guidance helped me a lot to adjust. Nikos, Giorgos and Valanto, I really enjoyed spending time with you.

I would also like to thank my former supervisor during my master, Dr. Dimitra Hadjipavlou-Litina, who was the first to introduce me in the area of medicinal chemistry and has always encouraged me. My dear friends from this lab, Katerina, Eleni, Maria, Xristos, Thaleia, Anna-Maria, who are always eager to meet and spend time together. Moreover, my supervisors in the National Hellenic Research Foundation, Dr. George Heropoulos and Dr. Barry Steele for the valuable experience there. Cecile, Georgia and Yakinthi thanks for the great memories.

Finally, I would like to thank my beloved family for the love, encouragement and support during this long journey.

Markella 18/11/2019

(9)

Referenties

GERELATEERDE DOCUMENTEN

Advanced techniques such as radiotracers for immunoPET imaging of PD-1 checkpoint expression on tumor-infiltrating lymphocytes and PD-L1 in general might therefore become

The co-crystal structure of human PD-1 and PD-L1 is expected to be a valuable starting point for the design of novel inhibitors, along with the recent crystal structures

Then, the solvent was removed under reduced pressure and the crude reaction mixture was purified by column chromatography (eluent: PE – EA [0 to 100% EtOAc in PE]).. For

With the optimized one-pot reaction conditions in hand, the scope of the “Ugi-4CR/cyclization” reaction was further investigated by reacting propargylamine with

A Ugi 4-component reaction with indole-2-carboxylic acid and an aniline followed by a Pd-catalyzed cyclization yields tetracyclic indoloquinolines in good to moderate

The reaction mixture was stirred at room temperature for 24 h to obtain intermediates A; then the solvent was removed and acetic anhydride [0.5 M] and 4N HCl in dioxane (1.0

After the completion of the reaction, the mixture was concentrated under reduced pressure and in the residue was added aryl chloride 6 (0.75 mmol), pyridine (1 ml) and the

The catalytic dyad (D35 and D 219) is represented by stick models. Oxygen atoms are colored in red and nitrogen atoms in blue. On the right, close-up view of the accommodation